Compare MLEC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLEC | ACON |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | MLEC | ACON |
|---|---|---|
| Price | $0.41 | $5.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 131.7K | 61.7K |
| Earning Date | 01-30-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,483.00 |
| Revenue This Year | $20.42 | $145.39 |
| Revenue Next Year | $30.00 | $145.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 170.36 | 36.91 |
| 52 Week Low | $0.39 | $5.55 |
| 52 Week High | $8.00 | $3,499.49 |
| Indicator | MLEC | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 42.44 |
| Support Level | $0.41 | $5.71 |
| Resistance Level | $0.48 | $6.89 |
| Average True Range (ATR) | 0.05 | 0.64 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 12.36 | 11.83 |
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.